External validators converging: multiple independent outside parties have recently, concretely endorsed the company with
The model's full reasoning — Q2 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了多个独立外部方近期采取了具体行动,并认为这些行动验证了公司未来增长轨迹,且这些贡献尚未完全反映在已报告结果中。 分析记录内容: - 管理层提到与ValueHealth的合作伙伴关系,收购了其少数股权和新建项目,这是具体的投资和合作行动。 - 还提到与Privia的合作(在蒙大拿州),但未明确说明Privia近期是否投入了具体资源或采取了行动,仅表示“继续讨论更广泛的关系”。 - 提到商业合同续约(每年1/3),但这是常规续约,非新的大额承诺。 - 提到医生招聘(新增250名医生),但医生是独立个体,其行动是加入设施,但这是公司自身招聘成果,非外部方独立背书。 - 提到收购多个ASC(手术中心),但这是公司自身的收购行为,非外部方投资。 - 没有明确提到两个或以上独立外部方(如大客户、合作伙伴、投资者等)近期采取了具体且难以逆转的行动,并共同验证公司未来增长。 管理层主要强调自身收购、招聘和运营成果,而非外部方独立背书。ValueHealth是合作伙伴,但属于公司自身交易。Privia关系未明确具体行动。因此,不符合“至少两个独立外部方”的条件。 答案:NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MMLP | Martin Midstream Partners L.P. | Q2 2024 | 2024-07-18 | B |
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| ICCM | IceCure Medical Ltd | Q3 2023 | 2023-11-15 | D |
| AIRG | Airgain, Inc. | Q3 2023 | 2023-11-09 | F |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| NVAX | Novavax, Inc. | Q3 2023 | 2023-11-09 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| DXLG | Destination XL Group, Inc. | Q2 2023 | 2023-08-24 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Q4 2022 | 2022-11-28 | D |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| ICL | ICL Group Ltd | Q3 2022 | 2022-11-09 | B+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| AWRE | Aware, Inc. | Q3 2022 | 2022-10-30 | F |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| CDXC | ChromaDex Corporation | Q4 2021 | 2022-03-09 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| ALHC | Alignment Healthcare, Inc. | Q3 2021 | 2021-11-06 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| HPE | Hewlett Packard Enterprise Company | Q2 2018 | 2018-05-22 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| EPAM | EPAM Systems, Inc. | Q4 2017 | 2018-02-16 | B |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| MXL | MaxLinear, Inc. | Q2 2017 | 2017-08-08 | C+ |
| CNS | Cohen & Steers, Inc. | Q2 2017 | 2017-07-20 | B |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| NTCT | NetScout Systems, Inc. | Q2 2017 | 2016-10-27 | D |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
| ACCO | ACCO Brands Corporation | Q1 2016 | 2016-04-27 | B+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| ENLC | EnLink Midstream, LLC | Q4 2015 | 2016-02-17 | C+ |
| JJSF | J&J Snack Foods Corp. | Q1 2016 | 2016-01-26 | C |
DUOT · Q4 2023 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript mentions new AI subscription and support services contracts with two major railroads, which are concrete recent actions by two independent outside parties. However, management describes these as "just the beginning," indicating that the business implied is early relative to the company's reported size. This meets the criteria for YES under the specific conditions provided but the overall context of poor financials and the need for capital infusion suggests the actions may not fully align with the "validating a trajectory whose contribution is still mostly ahead" aspect in a way that overrides the NO criteria for rescue financing or balance-sheet repair. The patent grant is an approval but not a party putting money or orders behind the company in the required sense. Partnerships with Dell and NVIDIA are strengthened but not new concrete actions costing to reverse. Thus, the answer is NO.
TENB · Q2 2021 → YESThe question is about whether management describes more than one independent outside party recently putting something real behind the company, and treating this as validating a trajectory still mostly...YES The transcript shows management describing multiple independent outside parties taking concrete recent actions that validate the company's trajectory as still early relative to reported results. Specifically, NIST selected Tenable as one of 18 technologies for its Zero Trust initiative, granting formal approval and admission. Separately, the company entered a $375 million credit agreement with lenders to support growth, providing capital backing. These actions—approval and investment—are treated by management as endorsements of the business's early-stage potential, with references to ongoing deployments and pipeline activity in areas like OT and AD that exceed the current reported size. The parties are independent, and the actions are recent and in motion rather than reflective of fully realized results.
CRGO · Q1 2024 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript describes partnerships or expansions with United Airlines, Delta Cargo, Singapore Airlines, and Fits Cargo, but these are presented as ongoing or expanding relationships rather than new, concrete recent actions from multiple independent parties that validate an early-stage trajectory. The United Airlines example is a specific commitment to build a portal, yet the 49 carrier sellers and new additions are framed as rollouts already reflected in results, with pipeline mentions indicating future activity. Management connects these to growth but does not clearly treat the convergence as validating a trajectory mostly ahead of reported results in a way that meets the criteria for multiple independent endorsements with costly commitments.